The Centre for Eye Research Australia (CERA)
90615802670
VIC 3002
cera.org.au
CERA.eye
2493851
CERA Foundation Ltd
The CERA Foundation Ltd is a nonprofit organization based in Australia, serving as the trustee for the Centre for Eye Research Australia Foundation, which is classified as a public ancillary fund[1][3].
Purpose and Activities
The primary purpose of the CERA Foundation Ltd is to support research activities related to eye diseases and vision impairment. The Centre for Eye Research Australia, associated with this foundation, conducts extensive research into various eye diseases and works towards developing new treatments and cures to prevent vision loss and blindness.
Structure and Registration
CERA Foundation Ltd is registered as an Australian Public Company. It is active since November 2016 and is not currently registered for GST[5]. The organization's activities are focused on fostering innovations and breakthroughs in ophthalmic care, aiming to enhance health outcomes for individuals suffering from vision impairments.
Clinical Trials and Innovation
The Centre for Eye Research Australia has established Cerulea Clinical Trials, a not-for-profit clinical trials centre, which plays a crucial role in advancing ophthalmic treatments and therapies[2]. This initiative underscores the foundation's commitment to innovative research and practice in the field of eye health.
Philanthropic Engagement
CERA encourages philanthropic support to drive its mission forward. The organization offers opportunities for major donors to contribute to research efforts, matching their interests with CERA's expertise to maximize the impact of donations[4]. This collaborative approach helps in accelerating medical breakthroughs and fostering a global community committed to eliminating vision loss and blindness.
[1] https://www.acnc.gov.au/charity/charities/1cf97b95-3aaf-e811-a960-000d3ad24282/profile [2] https://www.cera.org.au [3] https://www.acnc.gov.au/charity/charities/1cf97b95-3aaf-e811-a960-000d3ad24282/documents/e4fb4825-e71e-ef11-840a-000d3acb22e5 [4] https://www.cera.org.au/philanthropy/ [5] https://abr.business.gov.au/ABN/View/90615802670
Podobné organizace
Sydney Eye Hospital Foundation Trust |
|
Lions Eye Institute Limited |
|
Layton Vision Foundation Limited |
|
Sydney Eye Hospital Foundation Ltd |
|
FUTURE VISION FOUNDATION LIMITED |
Podobné organizace global
Center for Eye Research Inc |
|
National Foundation for Eye Research |
|
Eye and Ear Foundation Inc. |
|
Foundation Fighting Blindness, Inc. |
|
Retina Research Foundation of America |
Podobná návštěvnost
Art Salon S, z. s. |
|
OBRAZ - Obránci zvířat, z. s. |
|
NFNZ - Nadační fond nezávislé žurnalistiky |
|
Centrum Anabell, z. ú. |
|
Muzeum přírody Český ráj z. s. |
Podobně sociální sítě (9956)
Nadace THE KELLNER FAMILY FOUNDATION10000 |
|
Toulcův dvůr, z.s.10000 |
|
SPOLEČNĚ-JEKHETANE, o.p.s.10000 |
|
Čmeláci PLUS z.s.10000 |
|
Kočkovité šelmy z. ú.10000 |
Novinky
Like most proud parents, you probably take many photos of your young ones. 📸 What you notice can be very important. 👁️ A crossed eye, and sometimes a white pupil, can be an early sign of retinoblastoma – a rare but serious childhood cancer. Dr Sandra Staffieri AO has put together a guide to recognising the early signs of eye problems – including retinoblastoma - in babies and young children. Get your guide via the link in the comments below. 👇 Take a closer look this #WorldRetinoblastomaWeek (fb)
Today, we acknowledged Global Accessibility Awareness Day by hosting an event featuring special guest and accessibility expert John Simpson AM. He shared some important ways we can be thinking about digital accessibility for everyone – inclusive of all abilities. John has long been an advocate for removing barriers and improving accessibility. In 2020, he was awarded the Member of the Order of Australia “for significant service to people who are blind or have low vision”. The session has provided us with actionable insights toward accessibility and inclusion. Here at CERA, we're progressing our accessibility journey and continually striving to make improvements across all our modes of communication. #GAAD #Accessibility Pictured below (from left): John A. Simpson AM and CERA Consumer Involvement and Advocacy Lead Fleur O'Hare stand together in front of the CERA logo at reception. (fb)
Poslední komentáře
🌟 So inspired by CERA’s commitment to advancing eye research! Together, we can bring hope to those affected by vision loss. Let’s support this vital work! 💪💙 #HopeInSight #EyeResearchdetail |
|
👁️✨ Amazing to see the groundbreaking work being done on glaucoma detection! Every bit of research counts in the fight against blindness. Proud to support CERA! 🙌 #VisionForAll #CERAFoundationdetail |
Poslední diskuze
1. How can community engagement and consumer involvement enhance the effectiveness of eye research initiatives at CERA?Odpovědí: 3, Naposledy před 1 den detail |
|
2. What role do you think emerging technologies, like AI, will play in revolutionizing the diagnosis and treatment of eye conditions in the next decade?Odpovědí: 3, Naposledy před 1 den detail |
V okolí
4.5
VIC 3002
O společnosti
- H41, H01 -
CERA Science Research About Support Our Work Eye Conditions News Contact Follow Us Donate Donate to CERA Subscribe Get monthly updates Clinical trials Take part in research Apply filters to your search Hope in sight TM Our research is bringing hope to people affected by vision loss and blindness Donate Now Spotlight on glaucoma Read More Event 16th Annual Gerard Crock Lecture Read More Video Next generation gene technologies Read More Consumer involvement Help shape the future of vision research Read More Celebrating Cerulea Clinical Trials Cerulea Clinical Trials CERAs new notforprofit clinical trials centre is up and running. Read more Take part in research Help shape the future of vision research by taking part in a clinical study. Learn more Latest News Could AI eye scans help doctors identify heart disease and stroke risk. 19 April 2025 New research examines the benefits of using AI retinal imaging to screen for cardiovascular disease in GP clinics and identifies areas for improvement.
Oko Alianční a advokační organizace
